NFLX:NASDAQNetflix, Inc. Analysis
Data as of 2026-03-09 - not real-time
$97.54
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Netflix (NFLX) is trading at $97.5, comfortably above its 20‑day ($85.7) and 50‑day ($86.8) moving averages but still below the 200‑day average ($109.6), signaling short‑term strength within a longer‑term bearish backdrop. The stock’s RSI sits at 69, nearing overbought territory, while a bullish MACD histogram (+2.26) and rising volume underscore recent momentum. Fundamentally, the company posted 17.6% revenue growth, a 48.5% gross margin and a stellar 42.8% ROE, with forward earnings expected to lift the forward P/E to 25.4.
Recent headlines highlight management’s decision to abandon the Warner Bros. acquisition, a move that investors have praised for preserving balance‑sheet discipline and sharpening focus on organic growth and advertising. The market sentiment is extremely bullish (Fear & Greed Index “Extreme Greed”), and analysts collectively rate the stock as a “Buy” with a median price target of $112, implying roughly a 15% upside from current levels.
Recent headlines highlight management’s decision to abandon the Warner Bros. acquisition, a move that investors have praised for preserving balance‑sheet discipline and sharpening focus on organic growth and advertising. The market sentiment is extremely bullish (Fear & Greed Index “Extreme Greed”), and analysts collectively rate the stock as a “Buy” with a median price target of $112, implying roughly a 15% upside from current levels.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and increasing volume
- Positive market reaction to deal‑discipline decision
- Price approaching key resistance at $100.2
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high ROE
- Forward earnings expansion lowering P/E
- Analyst consensus targets around $112
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Price still below 200‑day average indicating long‑term bearish bias
- High valuation multiples relative to industry peers
- Need for sustained subscriber and ad revenue growth amid competitive pressures
Key Metrics & Analysis
Financial Health
Revenue Growth17.60%
Profit Margin24.30%
P/E Ratio38.6
ROE42.76%
ROA15.25%
Debt/Equity63.78
P/B Ratio15.5
Op. Cash Flow$10.1B
Free Cash Flow$24.8B
Industry P/E18.1
Technical Analysis
TrendBearish
RSI69.4
Support$75.01
Resistance$100.19
MA 20$85.67
MA 50$86.84
MA 200$109.57
MACDBullish
VolumeIncreasing
Fear & Greed Index100
Valuation
Fair Value$166.39
Target Price$113.12
Upside/Downside15.98%
GradeFair
TypeGrowth
Risk Assessment
Beta0.72
Volatility50.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
IMPPP
Imperial Petroleum Inc. - 8.75% Series A Cumulative Redeemable Perpetual Preferred Shares
STOCKAVGO
Broadcom Inc.
STOCKMH
McGraw Hill, Inc.
STOCKMSBIP
Midland States Bancorp, Inc. - Depositary Shares Each Representing a 1/40th Interest in a Share of 7.750% Fixed-Rate Reset Non-Cumulative Perpetual Preferred St
STOCKMARK
AlRayan Bank
STOCKPCRX
Pacira BioSciences, Inc.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.